Summary of Significant Accounting Policies - Additional Information (Details)			1 Months Ended	12 Months Ended
	Oct. 26, 2018 USD ($)	Mar. 28, 2018 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2021 USD ($) item segment	Dec. 31, 2020 USD ($)	Aug. 03, 2020 USD ($)
Basic And Diluted Earnings Per Share [Line Items]
Number Of Wholly Owned Subsidiaries | item				3
Number of business segment | segment				1
Recognized grants receivable				$ 1,500,000
Restricted Cash				50,000
Impairment of Long-Lived Assets Held-for-use				0
Cash insured by FDIC				250,000
Maximum Research And Development Expenses Reimbursement		$ 200,000
Grants Receivable				$ 1,800,000
Restricted Stock Units (RSUs)
Basic And Diluted Earnings Per Share [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				4 years
Phase Two
Basic And Diluted Earnings Per Share [Line Items]
Grants Receivable in fiscal year	$ 1,100,000					$ 500,000
Grants awarded, period one	1 year
Grants awarded, period two	2 years
Grant period, extension term			1 year
Grant period, extension cost			$ 0
Grant Income Recognized				$ 165,000	$ 447,000